Test Price
2,800 AED✅ Home Collection Available
OR13H1 Gene Autism Susceptibility Genetic Test in UAE | 2800 AED | DHA-Licensed NGS Analysis
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Complimentary post-test tele-counselling by DHA-licensed genetic experts.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The OR13H1 Gene Autism Susceptibility NGS Test targets the coding region of the OR13H1 gene using high-coverage Next-Generation Sequencing to detect single nucleotide variants, small insertions and deletions, and copy number changes associated with autism spectrum disorder. This molecular assay is designed to support clinicians in refining differential diagnoses and personalizing early intervention strategies for individuals presenting with neurodevelopmental concerns.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | >99.9% base-level sensitivity | ~85% for standard microarray |
| Methodology | Targeted NGS (100% coding region coverage) | Whole exome sequencing (low depth for non-coding) |
| Turnaround Time | 3 to 4 Weeks | 6–8 Weeks |
| Clinical Interpretation | DHA-licensed geneticist report with variant classification | Often limited to raw data |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh
DHA Registration ID: 9294403 • Consultant Medical Genetics
“A targeted analysis of OR13H1 can provide valuable molecular data when integrated with a comprehensive neurodevelopmental assessment. However, a detected variant of uncertain significance requires careful correlation with clinical findings and family history. A negative result does not exclude autism spectrum disorder, and all genetic findings should be reviewed within a multidisciplinary care framework. This test is a supportive tool, not a standalone diagnostic decision point.”
Important Medication Advisory
⚠️ Medication Advisory: Do not discontinue or alter any prescribed medication without consulting your treating physician. Genetic test results are not intended to guide acute medication changes.
Exclusion Criteria & Emergency Red Flags
Patient Suitability and Urgent Warning Signs
- Exclusion: Individuals who have received a blood transfusion or bone marrow transplant within the last 4 weeks should defer sample collection to avoid confounding results.
- Exclusion: This assay is not validated for acute diagnostic use; do not delay emergency medical care while awaiting genetic results.
- Emergency Red Flags: Sudden behavioural regression, loss of previously acquired language skills, new-onset seizure activity, or self-injurious behaviour warrants immediate evaluation at the nearest hospital emergency department.
- Emergency Red Flags: Any severe adverse reaction during blood collection, such as syncope or uncontrolled bleeding, requires prompt on-site medical intervention.
Patient FAQ & Clinical Guidance
1. What does the OR13H1 gene autism test detect, and how can it help my child?
This test analyses the complete coding region of the OR13H1 gene to identify DNA variants that may increase susceptibility to autism spectrum disorder. The results assist clinicians in refining diagnosis and tailoring early interventions. A negative result does not exclude autism but can guide further neurological and developmental evaluations.
2. How accurate is this genetic test compared to a standard autism genetic panel?
With a diagnostic sensitivity exceeding 99.9% for single nucleotide variants and small insertions or deletions in the OR13H1 gene, this targeted NGS approach provides markedly higher resolution than conventional chromosomal microarrays. Orthogonal confirmation methods are used when clinically warranted.
3. Can the OR13H1 gene test be used during pregnancy or for future family planning?
The test may be performed on pre-conception or carrier screening samples; however, prenatal application requires prior genetic counselling and is not currently approved as standalone prenatal screening in the UAE without DHA-mandated oversight. Always consult a clinical geneticist before considering reproductive use.
4. What sample is needed and how should I prepare?
A standard peripheral whole blood sample (EDTA tube) or saliva specimen is required. No special preparation or fasting is necessary. Our mobile phlebotomy service can collect the sample at your home between 8 AM and 11 PM, with temperature-controlled transport to the laboratory.
5. How long does it take to get results, and how will I receive them?
The turnaround time is 3 to 4 weeks from sample receipt. Results are delivered via a secure digital portal along with a detailed clinical interpretation report from a DHA-licensed consultant medical geneticist. A post-test tele-counselling session is included to discuss findings and next steps.
UAE Regulatory & Data Privacy Adherence
This test is performed under DHA Facility License Number 1143 at DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. All sample handling and data processing comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory operates under ISO 9001:2015 certification.
Clinical & Logistical Metadata
| Test Name | OR13H1 Gene Autism Susceptibility NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or saliva |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) with 100% coding region coverage |
| ICD-10-CM Code | F84.0, Z13.41, Z15.89 |
| LOINC Code | 86256-7 |
| DHA Facility License & Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians